Search Results 21-30 of 16909 for Nilutamide

  1. A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS) - Mayo Clinic

    ... nilutamide), steroidal antiandrogens (megestrol acetate, cyproterone acetate), oral ketoconazole, chemotherapy, immunotherapy, estrogens, radiopharmaceuticals.

  2. A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer - Mayo Clinic

    Prior systemic treatment with androgen deprivation therapy and/or first-generation anti-androgen (e.g., bicalutamide, nilutamide, flutamide) for biochemically ...

  3. Nifurtimox (oral route) - Side effects & dosage - Mayo Clinic

    Nifurtimox is used to treat Chagas disease (American Trypanosomiasis) in children. Chagas disease is a potentially life-threatening disease caused by the ...

  4. Cancer Treatment Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C137 in ...

  5. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    nilutamide, bicalutamide, enzalutamide, or other androgen-receptor inhibitors within 2 weeks before randomization - Radiation therapy within 4 weeks (2 ...

  6. Lisocabtagene maraleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Lisocabtagene maraleucel injection is also used to treat follicular lymphoma (FL) that has come back (relapsed) or did not respond to the treatment (refractory) ...

  7. A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

    ... nilutamide are not counted toward this limit; AND; Disease progression after treatment with 1 prior line of taxane-based chemotherapy for castration ...

  8. A Study of Treatment with Docetaxel and Prednisone, with or without Vaccine Therapy, for Patients who have Metastatic Hormone-Resistant Prostate Cancer - Mayo Clinic

    ... nilutamide) prior to randomization; If demonstrates an anti-androgen withdrawal response, defined as a ≥ 25% decline in PSA within 4-6 week of stopping a ...

  9. Selumetinib (oral route) - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule. Back to top ...

  10. Nesiritide (intravenous route) - Side effects & dosage - Mayo Clinic

    Nesiritide is used for patients who have severe congestive heart failure that has recently become worse. Nesiritide is for patients who are short of breath ...